Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Rα-/- mice

Hepatology

Volumn 49, Issue 1, 2009, Pages 133-140

  Hsu, Willy ^a   Zhang, Weici ^a   Tsuneyama, Koichi ^b   Moritoki, Yuki ^a   Ridgway, William M ^c   Ansari, Aftab A ^d   Coppel, Ross L ^e   Lian, Zhe Xiong ^a   Mackay, Ian ^e   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TOYAMA   (Japan)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 12P40; INTERLEUKIN 2 RECEPTOR ALPHA; MITOCHONDRION ANTIBODY; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BODY WEIGHT; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CHOLANGITIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENTERITIS; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; COLON; GENETICS; IMMUNOLOGY; LIVER; LIVER MITOCHONDRION; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SMALL INTESTINE;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; AUTOIMMUNE DISEASES; CHOLANGITIS; COLON; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTESTINE, SMALL; LIVER; MICE; MICE, KNOCKOUT; MITOCHONDRIA, LIVER; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 58949098337     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22591     Document Type: Article

References (34)

1. Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 2006;27:50-53.
2. Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and autoimmunity. Eur J Immunol 2008;38:921-924.
3. Horwitz BH. The straw that stirs the drink: Insight into the pathogenesis of inflammatory bowel disease revealed through the study of microflora-induced inflammation in genetically modified mice. Inflamm Bowel Dis 2007;13:490-500.
4. Kanai T, Watanabe M. Clinical application of human CD4+ CD25+ regulatory T cells for the treatment of inflammatory bowel diseases. Expert Opin Biol Ther 2005;5:451-462.
5. Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y, et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. HEPATOLOGY 2006;43:729-737.
6. Levings MK, Allan S, d'Hennezel E, Piccirillo CA. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv Immunol 2006;92:119-155.
7. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995;3:521-530.
8. -/-) mice and the development of primary biliary cirrhosis. HEPATOLOGY 2006;44:1240-1249.
9. Lian ZX, Okada T, He XS, Kita H, Liu YJ, Ansari AA, et al. Heterogeneity of dendritic cells in the mouse liver: Identification and characterization of four distinct populations. J Immunol 2003;170:2323-2330.
10. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987;138:3525-3531.
11. Leung PS, Iwayama T, Prindiville T, Chuang DT, Ansari AA, Wynn RM, et al. Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. HEPATOLOGY 1992;15:367-372.
12. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6:1142-1151.
13. Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice: Disease development is prevented by cotransfer of puri.ed CD4+ T cells. J Exp Med 1993;178:237-244.
14. Powrie F, Coffman RL. Cytokine regulation of T-cell function: Potential for therapeutic intervention. Trends Pharmacol Sci 1993;14:164-168.
15. Powrie F, Uhlig H. Animal models of intestinal inflammation: Clues to the pathogenesis of inflammatory bowel disease. Novartis Found Symp 2004; 263:164-174; discussion 174-168, 211-168.
16. Menager-Marcq I, Pomie C, Romagnoli P, van Meerwijk JP. CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 2006;131:1775-1785.
17. Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol 2003;38:180-185.
18. Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn's disease and analysis receptor/alpha analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008;14:437-445.
19. Tomita T, Kanai T, Fujii T, Nemoto Y, Okamoto R, Tsuchiya K, et al. MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis. J Immunol 2008;180:5291-5299.
20. Zhang Z, Hinrichs DJ, Lu H, Chen H, Zhong W, Kolls JK. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease? Int Immunopharmacol 2007;7: 409-416.
21. Rieger R, Gershwin ME. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 2007;28:76-84.
22. Rieger R, Leung PS, Jeddeloh MR, Kurth MJ, Nantz MH, Lam KS, et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 2006;27:7-16.
23. Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ, et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. HEPATOLOGY 2008;48:531-540.
24. Kita H, Lian ZX, Van de Water J, He XS, Matsumura S, Kaplan M, et al. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 2002;195:113-123.
25. Hanada S, Harada M, Koga H, Kawaguchi T, Taniguchi E, Kumashiro R, et al. Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. Liver Int 2003;23:3-11.
26. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: Effect of pro-inflammatory cytokines. Gut 1993;34:1245-1249.
27. Hsu W, Shu SA, Gershwin E, Lian ZX. The current immune function of hepatic dendritic cells. Cell Mol Immunol 2007;4:321-328.
28. Shimoda S, Harada K, Niiro H, Yoshizumi T, Soejima Y, Taketomi A, et al. Biliary epithelial cells and primary biliary cirrhosis: The role of liver-infiltrating mononuclear cells. HEPATOLOGY 2008;47:958-965.
29. John B, Crispe IN. Passive and active mechanisms trap activated CD8+ T cells in the liver. J Immunol 2004;172:5222-5229.
30. Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 1999;163:3202-3210.
31. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. HEPATOLOGY 2008;47:737-745.
32. Lan RY, Mackay IR, Gershwin ME. Regulatory T cells in the prevention of mucosal inflammatory diseases: Patrolling the border. J Autoimmun 2007; 29:272-280.
33. Lleo A, Invernizzi P, Selmi C, Coppel RL, Alpini G, Podda M, et al. Autophagy: Highlighting a novel player in the autoimmunity scenario. J Autoimmun 2007;29:61-68.
34. Lleo A, Selmi C, Invernizzi P, Podda M, Gershwin ME. The consequences of apoptosis in autoimmunity. J Autoimmun 2008; May 29 [Epub ahead of print].